Ansan, South Korea

Jee Woo Lee

This inventor holds 1 USPTO granted patent. Top assignee: Gruenenthal Gmbh. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jee Woo Lee. Retrieved from https://idiyas.com/inventor/jee-woo-lee-a6d58w92

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jee Woo Lee

Introduction

Jee Woo Lee is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of analgesic compounds. His work focuses on addressing various pain-related conditions through innovative chemical formulations.

Latest Patents

Jee Woo Lee holds a patent for "4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same." This patent describes compounds that serve as potent vanilloid receptor antagonists. These compounds are particularly useful in preventing, alleviating, or treating a wide range of pain diseases and inflammatory conditions, including acute pain, chronic pain, neuropathic pain, and various other disorders.

Career Highlights

Jee Woo Lee is currently associated with Gruenenthal GmbH, a company known for its focus on pain management and innovative pharmaceutical solutions. His work at Gruenenthal has allowed him to contribute to the development of effective treatments for pain and inflammatory diseases.

Collaborations

Throughout his career, Jee Woo Lee has collaborated with several professionals in the field, including Young Ho Kim and Hee Jin Kim. These collaborations have enhanced the research and development of his innovative compounds.

Conclusion

Jee Woo Lee's contributions to the field of analgesics highlight his commitment to improving pain management through innovative pharmaceutical solutions. His patent and ongoing work at Gruenenthal GmbH underscore the importance of research in developing effective treatments for various pain-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…